SCOPUS 정보 검색 플랫폼

Volumn 34, Issue 6, 2002, Pages 861-863

Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors

(4) Bertino Jr , Joseph S a Owens, Robert C b Carnes, Timothy D c Iannini, Paul B d

a BASSETT HEALTHCARE (United States)

b Maine Medical Center (Portugal)

c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE (United States)

d DANBURY HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMITRIPTYLINE; BUMETANIDE; CEFTRIAXONE; DOXAZOSIN; ENALAPRIL; FELODIPINE; FOLIC ACID; FUROSEMIDE; GATIFLOXACIN; GLIBENCLAMIDE; HYDROCODONE BITARTRATE; IMIPRAMINE; INSULIN; ISOSORBIDE MONONITRATE; LANSOPRAZOLE; MAGNESIUM OXIDE; METHOTREXATE; METOPROLOL; OMEPRAZOLE; PARACETAMOL; POTASSIUM; PRAVASTATIN; PREDNISONE; ROFECOXIB; THYROID HORMONE; UNINDEXED DRUG; VALSARTAN; VANCOMYCIN;

ADULT; AGED; ANAMNESIS; ARTICLE; BACTEREMIA; CARDIOTOXICITY; CASE REPORT; CATHETER INFECTION; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; STAPHYLOCOCCUS INFECTION; TORSADE DES POINTES;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; FLUOROQUINOLONES; HEART; HUMANS; LONG QT SYNDROME; MIDDLE AGED; RISK FACTORS; TORSADES DE POINTES; VENTRICULAR FIBRILLATION;

EID: 0037087166 PISSN: 10584838 EISSN: None Source Type: Journal
DOI: 10.1086/339075 Document Type: Article

Times cited : (55)

References (14)

1
- 0009737358
- The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications - Report on a Policy Conference of the European Society of Cardiology
- (2000) Cardiovasc Res , vol.47 , pp. 219-233
- Haverkamp, W.¹ Breithardt, G.² Camm, A.J.³

2
- 0033796125
- QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring
- (2000) J Cardiovasc Pharmacol , vol.36 , pp. 510-515
- Satoh, Y.¹ Sugiyama, A.² Chiba, K.³ Tamura, K.⁴ Hashimoto, K.⁵

3
- 0032702158
- QTc interval prolongation and polymorphic ventricular tachycardia associated with levofloxacin
- (1999) Am J Med , vol.107 , pp. 528-529
- Samaha, F.¹

4
- 0034525584
- Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects
- (2000) Clin Pharmacol Ther , vol.68 , pp. 658-666
- Demolis, J.L.¹ Kubitza, D.² Tenneze, L.³ Funck-Brentano, C.⁴

5
- 0003479052
- Princeton, NJ: Bristol-Myers Squibb
- (1999) Tequin [package insert]

6
- 25544466486
- Raritan, NJ: Ortho-McNeil Pharmaceutical
- (2000) Levaquin [package insert]

7
- 0003539482
- West Haven, CT: Bayer Laboratories
- (1999) Avelox [package insert]

8
- 0035180746
- + channels and their role in cardiac arrhythmias
- (2001) Am J Med , vol.110 , pp. 50-59
- Tristani-Firouzi, M.¹ Chen, J.² Mitcheson, J.S.³ Sanguinetti, M.C.⁴

9
- 0035170062
- + channel HERG
- (2001) Mol Pharmacol , vol.59 , pp. 122-126
- Kang, J.¹ Wang, L.² Chen, X.L.³ Triggle, D.J.⁴ Rampe, D.⁵

10
- 0035099042
- Gatifloxacin-induced QTc prolongation and ventricular tachycardia
- (2001) Pharmacotherapy , vol.21 , pp. 361-362
- Iannini, P.B.¹ Circiumaru, I.²

11
- 0035293881
- Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes
- (2001) Pharmacotherapy , vol.21 , pp. 301-309
- Owens Jr., R.C.¹

12
- 0013178105
- QTc prolongation associated with levofloxacin
- (2001) BMJ , vol.7277 , pp. 46-47
- Iannini, P.B.¹ Circiumaru, J.² Byazrova, E.³ Kramer, H.⁴

13
- 0034015298
- Quinolone-induced QT interval prolongation: A not so unexpected effect
- (2000) J Antimicrob Chemother , vol.45 , pp. 557-559
- Ball, P.¹

14
- 0034712552
- QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
- (2000) Lancet , vol.355 , pp. 1048-1052
- Reilly, J.G.¹ Ayis, S.A.² Ferrier, I.N.³ Jones, S.J.⁴ Thomas, S.H.L.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.